Tech Center 1700 • Art Units: 1645 1792
This examiner grants 54% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17914274 | ANTI-ACINETOBACTER BAUMANNII POLYCLONAL ANTIBODY (AB-pAb), AND USES THEREOF | Final Rejection | The Regents of the University of California |
| 18266625 | MICROORGANISM THAT PRODUCES USEFUL SUBSTANCE AND METHOD FOR PRODUCING USEFUL SUBSTANCE | Non-Final OA | KANEKA CORPORATION |
| 18322442 | METHODS FOR DIAGNOSING GASTRIC INTESTINAL METAPLASIA | Non-Final OA | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY |
| 18153727 | STAPHYLOCOCCUS AUREUS LEUKOCIDINS, THERAPEUTIC COMPOSITIONS, AND USES THEREOF | Non-Final OA | NEW YORK UNIVERSITY |
| 18995578 | BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS FOR ALLEVIATING PARKINSON'S DISEASE AND USE THEREOF | Non-Final OA | WECARE PROBIOTICS CO., LTD. |
| 18566194 | BACTERIAL STRAINS FOR USE IN PREVENTING, TREATING AND/OR REDUCING SYMPTOMS ASSOCIATED WITH A RHINOVIRUS-INDUCED COLD INFECTION | Non-Final OA | International N&H Denmark APS |
| 18191919 | Bifidobacterium longum for Preventing and/or Treating Essential Hypertension | Final Rejection | Jiangnan University |
| 18607330 | BACILLUS SUBTILIS ZF-1 AND APPLICATION THEREOF IN INHIBITING AFRICAN SWINE FEVER VIRUS | Non-Final OA | Wuhan Keqian Biology Co., Ltd. |
| 18008797 | METHOD OF INCREASING NISIN PRODUCTION IN LACTOCOCCUS LACTIS | Non-Final OA | Chr. Hansen A/S |
| 16347861 | DNA ANTIBODY CONSTRUCTS FOR USE AGAINST LYME DISEASE | Final Rejection | THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY |
| 17641031 | COMBINATION VACCINE FOR INTRADERMAL ADMINISTRATION | Non-Final OA | INTERVET INC. |
| 18392590 | TREATMENT OF CANCER USING BOTULINUM TOXIN AND NITROUS OXIDE | Non-Final OA | Penland Foundation |
| 18571132 | BROAD SPECTRUM PATHOGEN CONTROL IN PLANTS | Non-Final OA | FUNDACIÓN CENTRO DE EXCELENCIA EN INVESTIGACIÓN DE MEDICAMENTOS INNOVADORES EN ANDALUCÍA, MEDINA |
| 18479501 | PROTEINS AND NUCLEIC ACIDS USEFUL IN VACCINES TARGETING STAPHYLOCOCCUS AUREUS | Non-Final OA | Evaxion Biotech A/S |
| 18038901 | BIOMARKERS FOR MYCOBACTERIUM AVIUM PARATUBERCULOSIS | Non-Final OA | ABERYSTWYTH UNIVERSITY |
| 18256547 | AGRICULTURAL FORMULATION COMPRISING AT LEAST ONE BACTERIAL STRAIN B. SAFENSIS RGM 2450, AND/OR A BACTERIAL STRAIN B. SIAMENSIS RGM 2529 AND AGRICULTURAL EXCIPIENTS; USE OF THE FORMULATION AND METHOD FOR STIMULATING GROWTH AND/OR INCREASING CROP YIELDS AND/OR PROTECTING CROPS AGAINST DISEASES AND PESTS | Non-Final OA | BLANES SPA |
| 17758139 | IMMUNOTHERAPEUTIC TREATMENT OF CANCER | Final Rejection | IMMODULON THERAPEUTICS LIMITED |
| 18033232 | LACTIC ACID BACTERIUM FOR TREATMENT OF AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY | Final Rejection | Su Ching HU |
| 18027614 | NOVEL LACTIC ACID BACTERIA ISOLATED FROM AGED MEAT, AND USE THEREOF | Final Rejection | KOOKMINBIO, CORP. |
| 17896847 | COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATMENT OR PREVENTION OF CONDITIONS ASSOCIATED WITH HYPERPROLIFERATIVE CELLULAR DIVISION, DIABETES, IMMUNODEFICIENCY DISEASES, ALZHEIMER'S DISEASE OR AUTOIMMUNE DISEASES, AND TESTING SYSTEM AND METHOD | Final Rejection | Chai Foundation for Medical Research & Life Extension, Inc. |
| 17779676 | COMPOSITIONS FOR IMPROVING ATHLETIC PERFORMANCE AND METHODS OF USE THEREOF | Non-Final OA | FITBIOMICS INC. |
| 17627796 | Novel Xanthomonas Strains and Related Methods | Non-Final OA | Geoffrey Gardiner Dairy Foundation Limited |
| 16475541 | USE OF THE CPCR REGULATOR GENE FOR OBTAINING NEW RECOMBINANT STRAINS OF BACILLUS THURINGIENSIS WITH REDUCED SPORULATION CAPACITY | Final Rejection | Institute of Plant Protection, Chinese Academy of Agricultural Sciences |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy